Abstract
Incomplete killing was observed for caspofungin against Candida glabrata, which was associated with increased SLT2 expression and elevated chitin content. In contrast, fungicidal activity and no chitin increase were observed in an isogenic Δslt2 strain, suggesting a role for SLT2 and chitin production in the response of C. glabrata to caspofungin.
Up-regulation of the cell wall integrity (CWI) pathway in Candida albicans upon damage to the cell wall and increases in chitin have correlated with the paradoxical attenuation of caspofungin activity at clinically relevant supra-MIC concentrations (21, 22). Although this effect has not been observed in Candida glabrata (4, 20), studies have reported incomplete killing against some isolates (2, 3, 5, 23). In Saccharomyces cerevisiae, SLT2 encodes a mitogen-activated protein kinase of the CWI pathway that confers protection from damage to the cell wall. An SLT2 homolog has been identified in the C. glabrata genome sequence (http://cbi.labri.fr/Genolevures/index.php). Our objective was to evaluate the potential role of SLT2 and increases in chitin content in the escape of C. glabrata from the fungicidal activity of caspofungin.
A C. glabrata Δslt2 strain and its isogenic parent, C. glabrata 200989, were used in all experiments (7). Stock solutions of caspofungin acetate (Merck & Co., Inc., Whitehouse, NJ) were prepared in sterile distilled water and further diluted in RPMI broth buffered with 0.165 M morpholinepropanesulfonic acid (pH 7). The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) colorimetric assay was conducted at caspofungin concentrations from 0 to 32 μg/ml as previously described (6, 13). The absorbance was read at 492 nm, and readings were converted to percent absorbance with the growth control set at 100% and medium controls at 0%. Time-kill studies were performed using previously reported methods with caspofungin concentrations of 0, 0.125, 1.0, and 16.0 μg/ml (9). Fungicidal activity was defined as a ≥3-log10 (99.9%) reduction in CFU/ml from the starting inoculum (9).
For gene expression and chitin assays, strains were adjusted to a starting inoculum of ∼1 × 104 cells/ml and incubated at 37°C with shaking to ∼1 × 106 cells/ml. Cells were then exposed to caspofungin (0, 0.125, 1.0, and 16.0 μg/ml) for 10 min, 180 min, or 12 h. Cells were then harvested, and total RNA was extracted using MasterPure RNA Purification kits (Epicenter Biotechnologies, Madison, WI). Reverse transcription to cDNA was performed (GeneAmp RNA PCR kit, Applied Biosystems, Inc., Foster City, CA), and relative gene expression was determined by real-time PCR (ABI PRISM 7300 sequence detection system), with primers and probes specific for DNA carrying SLT2 and CHS3 as identified within the C. glabrata genome sequence database (Table 1). Relative gene expression levels were calculated by the 2−ΔΔCT method using ACT1 as the housekeeping gene (10). For chitin analysis, cells were exposed to caspofungin (0, 0.125, 1.0, and 16.0 μg/ml) for 12 h, cells were harvested, and chitin content was measured as previously described (18). Chitin content was corrected for pellet weight and expressed as changes from control levels. Each study was conducted in triplicate, and differences in fungal viability, CFU, chitin content, and gene expression were compared using one-way analysis of variance (ANOVA) with Tukey's posttest for multiple comparisons.
TABLE 1.
Primer and Taqman probe sequences used to measure gene expression by real-time PCRa
Gene | Description (references) | Primer and probe sequences |
---|---|---|
SLT2 | Gene encoding a mitogen-activated protein kinase of the protein kinase C cell wall integrity pathway (8, 17) | Forward, 5′-GGACTCCCATCCGCATCTG-3′ |
Reverse, 5′-TCCAACTCGCGTTCTAAATCG-3′ | ||
Probe, 5′-FAM-TCGAAACTCCATGAACAACGATTCCTTCC-TAMRA-3′ | ||
CHS3 | Gene encoding chitin synthase III (Chs3p), which is required for the majority of cell wall chitin in S. cerevisiae (19, 25) | Forward, 5′-CAAGATACAATCCGGAAGCAGAT-3′ |
Reverse, 5′-TGTCGTTCTTATTAGCCACATCGT-3′ | ||
Probe, 5′-FAM-ACCCAGATCGGACGGCTTTAAATAG-TAMRA-3′ | ||
ACT1 | Housekeeping gene | Forward, 5′-AATTGAGAGTCGCCCCAGAA-3′ |
Reverse, 5′-CTGTTAGACTTTGGGTTCATTGGA-3′ | ||
Probe, 5′-VIC-ACACCCAGTCTTGTTGACCGAGG-TAMRA-3′ |
TAMRA was the 3′ quencher dye, and FAM and VIC were the 5′ reporter dyes used for the probes in this study.
Complete growth inhibition did not occur at any caspofungin concentration tested against the parent strain, C. glabrata 200989, as measured by the XTT assay (Fig. 1A). Similarly, by time-kill analysis, fungicidal activity was not achieved at any concentration tested against strain 200989, with a maximum 1.6-log10 CFU/ml reduction (Fig. 1B). In contrast, a 100% reduction in absorbance was observed in the Δslt2 strain at concentrations of ≥0.5 μg/ml, and fungicidal activity was observed at 1 and 16 μg/ml (maximum 4.2-log10 CFU/ml reduction) (Fig. 1C). In addition, caspofungin (0.125 μg/ml) had excellent activity, with a 2.6-log10 reduction in CFU/ml. Increased expression of SLT2 was also observed at each caspofungin concentration versus control expression following 10 min of exposure (>2-fold; P < 0.05), and this was most elevated after 180 min (≥3.8-fold; P < 0.05) (Fig. 2A). However, SLT2 transcription was no longer increased at 12 h.
FIG. 1.
(A) In vitro XTT colorimetric assay. Percent absorbance (means ± standard deviations) for the parent C. glabrata strain, ATCC 200989 (•), and the corresponding Δslt2 (○) strain compared to results for the control are plotted on the y axis, and increasing concentrations of caspofungin (0 to 32 μg/ml) are plotted on the x axis. (B and C) Plots of log10 CFU/ml (means ± standard deviations) versus time for the parent C. glabrata strain, ATCC 200989 (B), and the Δslt2 strain (C) at the following caspofungin concentrations: ▪ and □, control; ▴ and ▵, 0.125 μg/ml; ⧫ and ⋄, 1.0 μg/ml; • and ○, 16.0 μg/ml.
FIG. 2.
(A) Relative expression of SLT2 in parent strain C. glabrata ATCC 200989 (means ± standard deviations) following caspofungin exposure for 10 min (dark bars), 180 min (gray bars), or 12 h (white bars). (B) Relative expression of CHS3 in the parent C. glabrata strain, ATCC 200989 (dark bars), or the corresponding Δslt2 strain (gray bars) following caspofungin exposure for 180 min. Expression levels were normalized using ACT1 as the housekeeping gene. (C) Changes in chitin content (means ± standard deviations) compared to control levels in the parent C. glabrata strain, ATCC 200989 (dark bars), and the corresponding Δslt2 strain (gray bars) following exposure to 0.125, 1.0, or 16.0 μg/ml of caspofungin for 12 h.
These phenotypic and genotypic data are consistent with findings in previous reports demonstrating a role of the CWI pathway in the coordination of the response to caspofungin-mediated cell wall damage. A rapid and transient induction of SLT2 transcription in S. cerevisiae following a brief exposure to caspofungin has previously been demonstrated (1, 17), while a 50% decrease in viable cells was observed in strains lacking Slt2p activity compared to the isogenic parent (17). Similarly, increased expression of the C. albicans homolog of SLT2, MKC1, has also been observed at elevated drug concentrations, where a paradoxical attenuation of caspofungin activity occurs, and this paradoxical phenotype was absent in a Δmkc1/Δmkc1 homozygous mutant (22).
We also examined chitin content following a caspofungin challenge. In strain 200989, CHS3 transcript levels increased by >2-fold at each caspofungin concentration after 180 min (P < 0.05) (Fig. 2B), accompanied by a >3.3-fold increase in chitin content versus control levels (P < 0.05) (Fig. 2C). In contrast, CHS3 expression did not significantly increase in the Δslt2 strain, nor was chitin content elevated following caspofungin challenge. These data suggest a link between SLT2 and increased chitin content upon cell wall damage by caspofungin in C. glabrata. The increase in chitin content was not unexpected, as other investigators have also demonstrated significant increases in chitin following exposures to different concentrations of echinocandins (16, 21). A link between the CWI pathway and chitin synthesis has also been described for C. albicans. A recent study reported activation of Mkc1p upon exposure to cell wall damaging agents, resulting in an up-regulation in CHS3 transcription and an increase in cell wall chitin (14). However, with the deletion of MKC1, CHS3 expression and chitin content remained unchanged.
While these data indicate an apparent association between SLT2, chitin content, and the response to caspofungin challenge in C. glabrata, further studies involving additional isolates are warranted. Although the CWI pathway appears to be conserved among fungi, this pathway and chitin synthesis have not been fully described for C. glabrata. Additionally, other potential mechanisms for caspofungin tolerance, including up-regulation of 1,3- and 1,6-β-glucan synthesis, increased export of cell wall components for cell wall repair, and the calcineurin pathway, require further investigation (11, 12, 15, 21, 22, 24). These initial data invite further studies since these may lead to strategies that improve outcomes for patients with invasive candidiasis.
Acknowledgments
Sponsored in part by grants from the American College of Clinical Pharmacy and the University of Texas at Austin College of Graduate Studies to N.P.W.
J.M.C., J.L.G., R.L.T., D.S.B, P.D.R., and T.D.E. have no conflicts of interest to disclose.
N.P.W. has received research support from Pfizer, Inc., and Schering-Plough.
Footnotes
Published ahead of print on 17 December 2007.
REFERENCES
- 1.Agarwal, A. K., P. D. Rogers, S. R. Baerson, M. R. Jacob, K. S. Barker, J. D. Cleary, L. A. Walker, D. G. Nagle, and A. M. Clark. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278:34998-35015. [DOI] [PubMed] [Google Scholar]
- 2.Barchiesi, F., E. Spreghini, A. W. Fothergill, D. Arzeni, G. Greganti, D. Giannini, M. G. Rinaldi, and G. Scalise. 2005. Caspofungin in combination with amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:2546-2549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barchiesi, F., E. Spreghini, S. Tomassetti, D. Arzeni, D. Giannini, and G. Scalise. 2005. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:4989-4992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chamilos, G., R. E. Lewis, N. Albert, and D. P. Kontoyiannis. 2007. Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob. Agents Chemother. 51:2257-2259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Clancy, C. J., H. Huang, S. Cheng, H. Derendorf, and M. H. Nguyen. 2006. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob. Agents Chemother. 50:2569-2572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cota, J., M. Carden, J. R. Graybill, L. K. Najvar, D. S. Burgess, and N. P. Wiederhold. 2006. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob. Agents Chemother. 50:3926-3928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Edlind, T. D., K. W. Henry, J. P. Vermitsky, M. P. Edlind, S. Raj, and S. K. Katiyar. 2005. Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast. Curr. Genet. 48:117-125. [DOI] [PubMed] [Google Scholar]
- 8.Heinisch, J. J., A. Lorberg, H. P. Schmitz, and J. J. Jacoby. 1999. The protein kinase C-mediated MAP kinase pathway involved in the maintenance of cellular integrity in Saccharomyces cerevisiae. Mol. Microbiol. 32:671-680. [DOI] [PubMed] [Google Scholar]
- 9.Klepser, M. E., E. J. Ernst, R. E. Lewis, M. E. Ernst, and M. A. Pfaller. 1998. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42:1207-1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408. [DOI] [PubMed] [Google Scholar]
- 11.Markovich, S., A. Yekutiel, I. Shalit, Y. Shadkchan, and N. Osherov. 2004. Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48:3871-3876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mazur, P., N. Morin, W. Baginsky, M. el-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-d-glucan synthase. Mol. Cell. Biol. 15:5671-5681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, P. J. Donnelly, and P. E. Verweij. 2001. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis[2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:4256-4263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Munro, C. A., S. Selvaggini, I. de Bruijn, L. Walker, M. D. Lenardon, B. Gerssen, S. Milne, A. J. Brown, and N. A. Gow. 2007. The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol. Microbiol. 63:1399-1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Osherov, N., G. S. May, N. D. Albert, and D. P. Kontoyiannis. 2002. Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:2462-2469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pfaller, M., J. Riley, and T. Koerner. 1989. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 8:1067-1070. [DOI] [PubMed] [Google Scholar]
- 17.Reinoso-Martin, C., C. Schuller, M. Schuetzer-Muehlbauer, and K. Kuchler. 2003. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot. Cell 2:1200-1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ride, J. P., and R. B. Drysdale. 1972. A rapid method for the chemical estimation of filamentous fungi in plant tissue. Physiol. Plant Pathol. 2:7-15. [Google Scholar]
- 19.Shaw, J. A., P. C. Mol., B. Bowers, S. J. Silverman, M. H. Valdivieso, A. Duran, and E. Cabib. 1991. The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle. J. Cell Biol. 114:111-123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Stevens, D. A., M. Espiritu, and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48:3407-3411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Stevens, D. A., M. Ichinomiya, Y. Koshi, and H. Horiuchi. 2006. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother. 50:3160-3161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wiederhold, N. P., D. P. Kontoyiannis, R. A. Prince, and R. E. Lewis. 2005. Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob. Agents Chemother. 49:5146-5148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wiederhold, N. P., L. K. Najvar, R. Bocanegra, D. Molina, M. Olivo, and J. R. Graybill. 2007. In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera. Antimicrob. Agents Chemother. 51:1616-1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhao, C., U. S. Jung, P. Garrett-Engele, T. Roe, M. S. Cyert, and D. E. Levin. 1998. Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol. Cell. Biol. 18:1013-1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ziman, M., J. S. Chuang, and R. W. Schekman. 1996. Chs1p and Chs3p, two proteins involved in chitin synthesis, populate a compartment of the Saccharomyces cerevisiae endocytic pathway. Mol. Biol. Cell 7:1909-1919. [DOI] [PMC free article] [PubMed] [Google Scholar]